Compare Stocks: OPRX, NRC, EVH, and AMWL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$13.66 +5.0%	$11.76	$3.71 ▼ $14.19	$225.99M	1.71	98,692 shs	40,323 shs
EVH Evolent Health	$4.10 -2.3%	$4.57	$2.10 ▼ $9.63	$462.98M	0.84	2.99 million shs	792,871 shs
NRC National Research	$22.15 +4.9%	$21.20	$11.01 ▼ $23.68	$503.91M	0.35	112,223 shs	42,136 shs
OPRX OptimizeRx	$7.71 +5.8%	$7.14	$4.54 ▼ $22.25	$145.65M	1.09	395,491 shs	52,614 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	0.00%	+0.23%	+4.40%	+48.44%	+97.09%
EVH Evolent Health	0.00%	-3.82%	-11.31%	-11.39%	-53.96%
NRC National Research	0.00%	-1.90%	-0.33%	+15.35%	+31.92%
OPRX OptimizeRx	0.00%	-7.37%	-16.40%	+37.03%	-57.93%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$13.66 +5.0%	$11.76	$3.71 ▼ $14.19	$225.99M	1.71	98,692 shs	40,323 shs
EVH Evolent Health	$4.10 -2.3%	$4.57	$2.10 ▼ $9.63	$462.98M	0.84	2.99 million shs	792,871 shs
NRC National Research	$22.15 +4.9%	$21.20	$11.01 ▼ $23.68	$503.91M	0.35	112,223 shs	42,136 shs
OPRX OptimizeRx	$7.71 +5.8%	$7.14	$4.54 ▼ $22.25	$145.65M	1.09	395,491 shs	52,614 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	0.00%	+0.23%	+4.40%	+48.44%	+97.09%
EVH Evolent Health	0.00%	-3.82%	-11.31%	-11.39%	-53.96%
NRC National Research	0.00%	-1.90%	-0.33%	+15.35%	+31.92%
OPRX OptimizeRx	0.00%	-7.37%	-16.40%	+37.03%	-57.93%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMWL American Well	2.00	Hold	$9.50	-30.43% Downside
EVH Evolent Health	2.63	Moderate Buy	$5.96	45.65% Upside
NRC National Research	2.50	Moderate Buy	$26.00	17.38% Upside
OPRX OptimizeRx	2.56	Moderate Buy	$11.43	48.15% Upside

Current Analyst Ratings Breakdown

Latest OPRX, NRC, EVH, and AMWL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/1/2026	EVH Evolent Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/25/2026	OPRX OptimizeRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/21/2026	NRC National Research	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
8/18/2026	EVH Evolent Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	EVH Evolent Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$5.00 ➝ $6.00
8/17/2026	EVH Evolent Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$5.00 ➝ $6.00
8/14/2026	OPRX OptimizeRx	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$11.00
8/14/2026	OPRX OptimizeRx	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
8/14/2026	OPRX OptimizeRx	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Outperform	$9.00 ➝ $11.00
8/13/2026	OPRX OptimizeRx	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$12.00
8/13/2026	AMWL American Well	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Hold	$7.50 ➝ $12.00

(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMWL American Well	$249.32M	0.91	N/A	N/A	$14.97 per share	0.91
EVH Evolent Health	$1.88B	0.25	$4.60 per share	0.89	$3.53 per share	1.16
NRC National Research	$137.39M	3.67	$1.32 per share	16.80	$0.62 per share	35.73
OPRX OptimizeRx	$109.43M	1.33	$1.04 per share	7.41	$6.88 per share	1.12

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMWL American Well	-$95.70M	-$4.77	N/A	N/A	N/A	-35.75%	-30.12%	-22.30%	11/3/2026 (Estimated)
EVH Evolent Health	-$534.51M	-$4.57	N/A	N/A	N/A	-24.08%	-4.27%	-1.06%	11/5/2026 (Estimated)
NRC National Research	$11.60M	$0.25	88.60	N/A	N/A	4.18%	164.26%	14.67%	10/26/2026 (Estimated)
OPRX OptimizeRx	$5.13M	$0.23	33.61	11.34	N/A	4.66%	9.44%	7.11%	11/5/2026 (Estimated)

Latest OPRX, NRC, EVH, and AMWL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	OPRX OptimizeRx	$0.1111	$0.16	+$0.0489	-$0.04	$20.20 million	$20.50 million
8/6/2026	Q2 2026	EVH Evolent Health	-$0.0104	$0.02	+$0.0304	-$0.25	$597.70 million	$484.50 million
8/4/2026	Q2 2026	AMWL American Well	-$0.86	-$0.59	+$0.27	-$0.59	$49.87 million	$52.05 million
7/28/2026	Q2 2026	NRC National Research	-$0.15	$0.31	+$0.46	-$0.15	$34.90 million	$35.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMWL American Well	N/A	N/A	N/A	N/A	N/A
EVH Evolent Health	N/A	N/A	N/A	N/A	N/A
NRC National Research	$0.64	3.03%	+19.88%	256.00%	N/A
OPRX OptimizeRx	N/A	N/A	N/A	N/A	N/A

Latest OPRX, NRC, EVH, and AMWL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/15/2026	NRC National Research	quarterly	$0.16	2.86%	9/25/2026	9/25/2026	10/9/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMWL American Well	N/A	2.90	2.89
EVH Evolent Health	2.52	1.24	1.24
NRC National Research	13.13	0.65	0.65
OPRX OptimizeRx	0.14	5.58	5.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMWL American Well	56.05%
EVH Evolent Health	N/A
NRC National Research	47.26%
OPRX OptimizeRx	76.47%

Insider Ownership

Company	Insider Ownership
AMWL American Well	12.84%
EVH Evolent Health	1.48%
NRC National Research	9.20%
OPRX OptimizeRx	7.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMWL American Well	1,040	16.55 million	14.43 million	Optionable
EVH Evolent Health	4,200	113.06 million	111.39 million	Optionable
NRC National Research	357	22.75 million	20.65 million	Optionable
OPRX OptimizeRx	100	18.84 million	17.42 million	Optionable

OPRX, NRC, EVH, and AMWL Headlines

Recent News About These Companies

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

September 14 at 8:00 AM | globenewswire.com

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

September 8, 2026 | globenewswire.com

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

September 2, 2026 | globenewswire.com

OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts

August 26, 2026 | marketbeat.com

AWM Investment Company Inc. Invests $1.38 Million in OptimizeRx Corp. $OPRX

August 26, 2026 | marketbeat.com

OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript

August 19, 2026 | finance.yahoo.com

OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...

August 13, 2026 | uk.finance.yahoo.com

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

August 13, 2026 | finance.yahoo.com

OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition

August 13, 2026 | seekingalpha.com

OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript

August 12, 2026 | seekingalpha.com

OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates

August 12, 2026 | zacks.com

OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline

August 12, 2026 | tipranks.com

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

August 12, 2026 | globenewswire.com

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

July 29, 2026 | globenewswire.com

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer

July 23, 2026 | globenewswire.com

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

June 30, 2026 | globenewswire.com

OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms

June 25, 2026 | quiverquant.comQ

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

June 25, 2026 | globenewswire.com

OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations

June 18, 2026 | finance.yahoo.com

OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust

June 9, 2026 | finance.yahoo.com

OptimizeRx to Participate in Upcoming Investor Conferences

June 1, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPRX, NRC, EVH, and AMWL Company Descriptions

American Well NYSE:AMWL

$13.66 +0.66 (+5.04%)

As of 01:46 PM Eastern

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Evolent Health NYSE:EVH

$4.10 -0.10 (-2.27%)

As of 01:47 PM Eastern

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

National Research NASDAQ:NRC

$22.15 +1.03 (+4.88%)

As of 01:47 PM Eastern

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

OptimizeRx NASDAQ:OPRX

$7.71 +0.42 (+5.82%)

As of 01:47 PM Eastern

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPRX, NRC, EVH, and AMWL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPRX, NRC, EVH, and AMWL Earnings

Compare Dividends

Latest OPRX, NRC, EVH, and AMWL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPRX, NRC, EVH, and AMWL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPRX, NRC, EVH, and AMWL Company Descriptions

American Well NYSE:AMWL

Evolent Health NYSE:EVH

National Research NASDAQ:NRC

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPRX, NRC, EVH, and AMWL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPRX, NRC, EVH, and AMWL Earnings

Compare Dividends

Latest OPRX, NRC, EVH, and AMWL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPRX, NRC, EVH, and AMWL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPRX, NRC, EVH, and AMWL Company Descriptions

American Well NYSE:AMWL

Evolent Health NYSE:EVH

National Research NASDAQ:NRC

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools